Target intelligence / Profile preview

Mitochondrial calcium uniporter complex (MCU complex)

Target
MCU complex
Molecular classification
Ion channel, Transport protein
01

Overview

The mitochondrial calcium uniporter (MCU) complex is the primary protein assembly responsible for the highly selective uptake of calcium ions (Ca2+) from the cytosol into the mitochondrial matrix (UniProt: Q8NE86). It consists of the pore-forming subunit MCU and regulatory components such as MICU1, MICU2, and EMRE, which together sense cytosolic Ca2+ concentrations and gate the channel accordingly (PubMed: 21666605, 21666606). Mitochondrial Ca2+ is a key regulator of aerobic metabolism, activating rate-limiting enzymes in the tricarboxylic acid (TCA) cycle to match energy supply with demand (Nature Reviews Molecular Cell Biology, 2018). However, pathological Ca2+ overload can trigger the opening of the mitochondrial permeability transition pore (mPTP), leading to mitochondrial swelling, membrane rupture, and the initiation of apoptotic or necrotic cell death (PubMed: 29305547). Because of its central role in cell survival and energetics, the MCU complex is a significant therapeutic target for treating ischemia-reperfusion injury, heart failure, and neurodegenerative diseases like Parkinson's and Alzheimer's (Frontiers in Pharmacology, 2020). Current pharmacological strategies focus on small-molecule inhibitors to protect cells from calcium-mediated damage or modulators that can restore calcium homeostasis in diseased states.

Other names
Mitochondrial calcium uniporterMCUCCDC109AMitochondrial Ca2+ uniporterMitochondrial calcium stores
02

Mechanism of action

Inhibition of mitochondrial calcium uptake to prevent mitochondrial calcium overload and subsequent opening of the permeability transition pore, or modulation of regulatory subunits to fine-tune metabolic flux.

03

Biological functions

Calcium homeostasisOxidative phosphorylationApoptosisSignal transductionMetabolic regulation
04

Disease associations

Neurodegenerative diseaseCardiovascular diseaseCancerIschemia-reperfusion injuryMuscular dystrophy
05

Safety considerations

Inhibition may impair ATP production in high-demand tissues like the heart and brainPotential for systemic metabolic toxicityDisruption of normal calcium signaling pathways
06

Interacting drugs

Ru360

4 more in the full profile.

07

Biomarkers

Mitochondrial membrane potentialReactive oxygen species (ROS) levelsCytosolic calcium transientsATP/ADP ratio

Beyond the preview

Go deeper on Mitochondrial calcium uniporter complex (MCU complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial calcium uniporter complex (MCU complex).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call